findmyKOL
Clinical trialNCT01638390CompletedPhase 1Interventional

Use of the VisuMax™ Femtosecond Laser

SponsorCarl Zeiss Meditec, Inc.Enrollment357Myopia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this clinical trial is to evaluate the safety and effectiveness of the Carl Zeiss Meditec VisuMax™ Femtosecond Laser lenticule removal procedure for the reduction or elimination of myopia from ≥ -1.00 D to ≤ -8.00 D with ≤ -0.50 D cylinder and MRSE (Manifest Refractive Spherical Equivalent) ≤ -8.25 D.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Dishler Laser Institute

    Greenwood Village, Colorado, United States

  • Bascom Palmer Eye Institute

    Miami, Florida, United States

  • Discover Vision Centers

    Leawood, Kansas, United States

  • Vance Thompson Vision

    Sioux Falls, South Dakota, United States

  • Davis Duehr Dean

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2012
Primary completion
30 Apr 2016
Completion
30 Apr 2016
Last update posted
2 Apr 2026
Registered enrollment
357
Registry id
NCT01638390

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.